日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Effect of antipsychotic medication use and type on mortality and cardiovascular risks in nursing home patients with dementia

抗精神病药物的使用及其类型对养老院痴呆症患者死亡率和心血管风险的影响

Okhravi, Hamid R; Fang, Fang; Hunter, Melissa P; Sheehan, Brynn E

Escitalopram for agitation in Alzheimer's dementia: a randomized controlled phase 3 trial

艾司西酞普兰治疗阿尔茨海默病痴呆症躁动:一项随机对照3期试验

Rajji, Tarek K; Baksh, Sheriza N; Shade, David M; Ismail, Zahinoor; Burhan, Amer M; Okhravi, Hamid R; Padala, Prasad R; Rosenberg, Paul B; Schneider, Lon S; Porsteinsson, Anton P; Lyketsos, Constantine G

System readiness and the patient care pathway for Alzheimer's disease diagnosis and treatment

系统准备情况以及阿尔茨海默病诊断和治疗的患者护理路径

Snider, B Joy; Biffi, Alessandro; Bozeat, Sasha; Clevenger, Carolyn; Farrar, Gill; Gitelman, Darren; Kolster, Rachel; Mattke, Soeren; Mielke, Michelle; Mukherjee, Debjani; Murphy, Jennifer; Okhravi, Hamid; Rabinovici, Gil D; Rentz, Dorene; Soria, Jose; Synder, Heather; Walker, Gregg; Mahinrad, Simin; Carrillo, Maria C; Weber, Christopher J

Functionally distinct pericyte subsets differently regulate amyloid-β deposition in patients with Alzheimer's disease

功能不同的周细胞亚群对阿尔茨海默病患者的β-淀粉样蛋白沉积具有不同的调控作用

Bohannon, Diana G; Long, Danielle; Okhravi, Hamid R; Lee, Sunhee C; De Jesus, Christopher Lawrence; Neubert, Thomas A; Rostagno, Agueda A; Ghiso, Jorge A; Kim, Woong-Ki

Clinical practice guideline for blood‐based biomarkers in the diagnostic workup of Alzheimer’s disease within specialized care settings: A report from the Alzheimer's Association

阿尔茨海默病专科护理机构中基于血液的生物标志物在阿尔茨海默病诊断评估中的临床实践指南:阿尔茨海默病协会报告

Grillner, L; Blomberg, J; Palmqvist, Sebastian; Whitson, Heather; Allen, Laura A; Carrillo, Maria C; Edelmayer, Rebecca M; Galasko, Douglas R; Hansson, Oskar; Kahaleh, Lara; Karikari, Thomas K; Mahinrad, Simin; McAteer, Mary Beth; Okhravi, Hamid; Paczynski, Madeline; Pahlke, Sarah; Schindler, Suzanne E; Suárez‐Calvet, Marc; Teunissen, Charlotte E; Zetterberg, Henrik; Tampi, Malavika

Comparing in-person and virtual delivery of a national ophthalmology revision course: a mixed-methods evaluation

比较全国眼科复习课程的面授和线上授课方式:一项混合方法评估

Jafari, Keya; Kerr, E; Seyed-Safi, A; Okhravi, N; Mathew, R G

Surgically induced scleritis after pars plana vitrectomy or scleral buckling surgery: a 12-year audit

玻璃体切除术或巩膜扣带术后手术诱发性巩膜炎:一项为期12年的审计

Raharja, Antony; Shah, Neil; Ahmed, Syed; Wagner, Siegfried Karl; Okhravi, Narciss; Bainbridge, James

Downstream Biomarker Effects of Gantenerumab or Solanezumab in Dominantly Inherited Alzheimer Disease: The DIAN-TU-001 Randomized Clinical Trial

Gantenerumab 或 Solanezumab 对显性遗传性阿尔茨海默病下游生物标志物的影响:DIAN-TU-001 随机临床试验

Wagemann, Olivia; Liu, Haiyan; Wang, Guoqiao; Shi, Xinyu; Bittner, Tobias; Scelsi, Marzia A; Farlow, Martin R; Clifford, David B; Supnet-Bell, Charlene; Santacruz, Anna M; Aschenbrenner, Andrew J; Hassenstab, Jason J; Benzinger, Tammie L S; Gordon, Brian A; Coalier, Kelley A; Cruchaga, Carlos; Ibanez, Laura; Perrin, Richard J; Xiong, Chengjie; Li, Yan; Morris, John C; Lah, James J; Berman, Sarah B; Roberson, Erik D; van Dyck, Christopher H; Galasko, Douglas; Gauthier, Serge; Hsiung, Ging-Yuek R; Brooks, William S; Pariente, Jérémie; Mummery, Catherine J; Day, Gregory S; Ringman, John M; Mendez, Patricio Chrem; St George-Hyslop, Peter; Fox, Nick C; Suzuki, Kazushi; Okhravi, Hamid R; Chhatwal, Jasmeer; Levin, Johannes; Jucker, Mathias; Sims, John R; Holdridge, Karen C; Proctor, Nicholas K; Yaari, Roy; Andersen, Scott W; Mancini, Michele; Llibre-Guerra, Jorge; Bateman, Randall J; McDade, Eric

Benefits and risks of FDA-approved amyloid-targeting antibodies for treatment of early Alzheimer's disease: Navigating clinician-patient engagement

FDA批准的靶向淀粉样蛋白抗体治疗早期阿尔茨海默病的益处和风险:如何协调临床医生与患者的互动

Rentz, Dorene M; Aisen, Paul S; Atri, Alireza; Hitchcock, Janice; Irizarry, Michael; Landen, Jaren; Matthews, Brandy R; Miller, David S; Mahinrad, Simin; Napoli, Salvatore; Okhravi, Hamid R; Petersen, Ronald C; Siemers, Eric R; Weber, Christopher J; Weisman, David C; Carrillo, Maria C

Evidence‐based Clinical Practice Guideline on the Use of Blood‐based Biomarkers in Alzheimer’s Disease: Presentation of Preliminary Evidence, and Opportunity for Public Comment

基于循证医学的阿尔茨海默病血液生物标志物临床实践指南:初步证据介绍及公众意见征询

Davis, Meghan F; Hu, Baofeng; Carroll, Karen C; Bilker, Warren B; Tolomeo, Pam; Cluzet, Valerie C; Baron, Patrick; Ferguson, Jacqueline M; Morris, Daniel O; Rankin, Shelley C; Lautenbach, Ebbing; Nachamkin, Irving; Tun, May Thet Hmu; Soe, Khin Htet Htet; Lwin, Khant Kaung Htet; Polepalli, Krishna Vamsy; Lin, May Yee; Paudel, Sumitra; Zeng, Desen; Li, Andrew; Klepper, Cameron; Roshni, Prarath; Iqbal, Saira P; Chung, Jessica; Lin, Yu Shia; Chapnick, Edward; Hansson, Oskar; Whitson, Heather; Edelmayer, Rebecca M; Allen, Laura A; Galasko, Douglas R; Karikari, Thomas K; Okhravi, Hamid; Paczynski, Madeline; Schindler, Suzanne E; Suarez‐Calvet, Marc; Teunissen, Charlotte; Zetterberg, Henrik; Mahinrad, Simin; Pahlke, Sarah; McAteer, Mary Beth; Kahaleh, Lara; Tampi, Malavika